Success Metrics

Clinical Success Rate
80.0%

Based on 4 completed trials

Completion Rate
80%(4/5)
Active Trials
1(14%)
Results Posted
25%(1 trials)
Terminated
1(14%)

Phase Distribution

Ph phase_2
2
29%
Ph early_phase_1
1
14%
Ph phase_1
4
57%

Phase Distribution

5

Early Stage

2

Mid Stage

0

Late Stage

Phase Distribution7 total trials
Early Phase 1First-in-human
1(14.3%)
Phase 1Safety & dosage
4(57.1%)
Phase 2Efficacy & side effects
2(28.6%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

80.0%

4 of 5 finished

Non-Completion Rate

20.0%

1 ended early

Currently Active

1

trials recruiting

Total Trials

7

all time

Status Distribution
Active(2)
Completed(4)
Terminated(1)

Detailed Status

Completed4
Terminated1
Not yet recruiting1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
1
Success Rate
80.0%
Most Advanced
Phase 2

Trials by Phase

Early Phase 11 (14.3%)
Phase 14 (57.1%)
Phase 22 (28.6%)

Trials by Status

terminated114%
completed457%
not_yet_recruiting114%
active_not_recruiting114%

Recent Activity

1 active trials
Showing 5 of 7
not_yet_recruitingphase_1

Sustained Release Oral Formulation For Treatment Of Parkinsons Disease

NCT07709741
active_not_recruitingphase_2

Phase 2 Trial to Evaluate Safety and Immunogenicity of Inventprise's (IVT) 25-valent Pneumococcal Conjugate Vaccine (IVT PCV-25) in Healthy Infants

NCT06790290
terminatedphase_2

A Study to Evaluate the Safety and Immunogenicity of an Adjuvanted RSV Vaccine in Healthy Older Adults

NCT03572062
completedearly_phase_1

Study to Evaluate Safety/Duration in Stomach of Extended Release Capsules in Healthy Adults

NCT03718390
completedphase_1

Study to Evaluate Taste Profile of Different JNJ-53718678 Oral Liquid Formulations in Healthy Participants

NCT02426632
View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials
NCT07709741Phase 1

Sustained Release Oral Formulation For Treatment Of Parkinsons Disease

Not Yet Recruiting
NCT06790290Phase 2

Phase 2 Trial to Evaluate Safety and Immunogenicity of Inventprise's (IVT) 25-valent Pneumococcal Conjugate Vaccine (IVT PCV-25) in Healthy Infants

Active Not Recruiting
NCT03572062Phase 2

A Study to Evaluate the Safety and Immunogenicity of an Adjuvanted RSV Vaccine in Healthy Older Adults

Terminated
NCT03718390Early Phase 1

Study to Evaluate Safety/Duration in Stomach of Extended Release Capsules in Healthy Adults

Completed
NCT02426632Phase 1

Study to Evaluate Taste Profile of Different JNJ-53718678 Oral Liquid Formulations in Healthy Participants

Completed
NCT00495274Phase 1

Bioequivalence and Food Effect Study in Healthy Volunteers

Completed
NCT00548769Phase 1

Firategrast (SB683699) Surface Area Study in Multiple Sclerosis Patients

Completed

All 7 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
7